Global and United States Alpha-1 Antitrypsin Drugs Market Insights, Forecast to 2027

Global and United States Alpha-1 Antitrypsin Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Alpha-1 Antitrypsin Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type
1.2.2 Parenteral
1.2.3 Inhalation
1.3 Market by Application
1.3.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Alpha-1 Antitrypsin Drugs Market Size, Estimates and Forecasts
2.1.1 Global Alpha-1 Antitrypsin Drugs Revenue 2016-2027
2.1.2 Global Alpha-1 Antitrypsin Drugs Sales 2016-2027
2.2 Global Alpha-1 Antitrypsin Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Alpha-1 Antitrypsin Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Alpha-1 Antitrypsin Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Alpha-1 Antitrypsin Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Alpha-1 Antitrypsin Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Region (2022-2027)
3 Global Alpha-1 Antitrypsin Drugs Competitor Landscape by Players
3.1 Global Top Alpha-1 Antitrypsin Drugs Manufacturers by Sales
3.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Alpha-1 Antitrypsin Drugs Manufacturers by Revenue
3.2.1 Key Alpha-1 Antitrypsin Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Alpha-1 Antitrypsin Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Drugs Revenue in 2020
3.2.6 Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Alpha-1 Antitrypsin Drugs Price by Manufacturers
3.4 Global Alpha-1 Antitrypsin Drugs Manufacturing Base Distribution, Product Types
3.4.1 Alpha-1 Antitrypsin Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alpha-1 Antitrypsin Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Alpha-1 Antitrypsin Drugs Market Size by Type (2016-2021)
4.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021)
4.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2016-2021)
4.1.3 Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Alpha-1 Antitrypsin Drugs Market Size by Application (2016-2021)
5.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021)
5.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2016-2021)
5.1.3 Alpha-1 Antitrypsin Drugs Price by Application (2016-2021)
5.2 Alpha-1 Antitrypsin Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Alpha-1 Antitrypsin Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Alpha-1 Antitrypsin Drugs Sales YoY Growth 2016-2027
6.1.2 United States Alpha-1 Antitrypsin Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Alpha-1 Antitrypsin Drugs Market Share in Global Market 2016-2027
6.2 United States Alpha-1 Antitrypsin Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Alpha-1 Antitrypsin Drugs Players by Sales (2016-2021)
6.2.2 United States Top Alpha-1 Antitrypsin Drugs Players by Revenue (2016-2021)
6.3 United States Alpha-1 Antitrypsin Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Alpha-1 Antitrypsin Drugs Price by Type (2016-2021)
6.4 United States Alpha-1 Antitrypsin Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Alpha-1 Antitrypsin Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Alpha-1 Antitrypsin Drugs Price Forecast by Type (2022-2027)
6.5 United States Alpha-1 Antitrypsin Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Alpha-1 Antitrypsin Drugs Price by Application (2016-2021)
6.6 United States Alpha-1 Antitrypsin Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Alpha-1 Antitrypsin Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Alpha-1 Antitrypsin Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2016-2027
7.2 North America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
7.2.1 North America Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021)
7.2.2 North America Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Alpha-1 Antitrypsin Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2016-2027
9.2 Europe Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
9.2.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021)
9.2.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
10.2.1 Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021)
10.2.2 Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Description and Business Overview
12.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Alpha-1 Antitrypsin Drugs Products Offered
12.1.5 Baxter Recent Development
12.2 CSL Behring
12.2.1 CSL Behring Corporation Information
12.2.2 CSL Behring Description and Business Overview
12.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Products Offered
12.2.5 CSL Behring Recent Development
12.3 Grifols
12.3.1 Grifols Corporation Information
12.3.2 Grifols Description and Business Overview
12.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Grifols Alpha-1 Antitrypsin Drugs Products Offered
12.3.5 Grifols Recent Development
12.4 Kamada
12.4.1 Kamada Corporation Information
12.4.2 Kamada Description and Business Overview
12.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Kamada Alpha-1 Antitrypsin Drugs Products Offered
12.4.5 Kamada Recent Development
12.5 Abeona Therapeutics
12.5.1 Abeona Therapeutics Corporation Information
12.5.2 Abeona Therapeutics Description and Business Overview
12.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Products Offered
12.5.5 Abeona Therapeutics Recent Development
12.6 Alnylam Pharmaceuticals
12.6.1 Alnylam Pharmaceuticals Corporation Information
12.6.2 Alnylam Pharmaceuticals Description and Business Overview
12.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Products Offered
12.6.5 Alnylam Pharmaceuticals Recent Development
12.7 Applied Genetic Technologies Corp
12.7.1 Applied Genetic Technologies Corp Corporation Information
12.7.2 Applied Genetic Technologies Corp Description and Business Overview
12.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Products Offered
12.7.5 Applied Genetic Technologies Corp Recent Development
12.8 Arrowhead Research Corporation
12.8.1 Arrowhead Research Corporation Corporation Information
12.8.2 Arrowhead Research Corporation Description and Business Overview
12.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Products Offered
12.8.5 Arrowhead Research Corporation Recent Development
12.9 Baxalta
12.9.1 Baxalta Corporation Information
12.9.2 Baxalta Description and Business Overview
12.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Baxalta Alpha-1 Antitrypsin Drugs Products Offered
12.9.5 Baxalta Recent Development
12.11 Baxter
12.11.1 Baxter Corporation Information
12.11.2 Baxter Description and Business Overview
12.11.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Baxter Alpha-1 Antitrypsin Drugs Products Offered
12.11.5 Baxter Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Alpha-1 Antitrypsin Drugs Industry Trends
13.2 Alpha-1 Antitrypsin Drugs Market Drivers
13.3 Alpha-1 Antitrypsin Drugs Market Challenges
13.4 Alpha-1 Antitrypsin Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alpha-1 Antitrypsin Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Parenteral
Table 3. Major Manufacturers of Inhalation
Table 4. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Alpha-1 Antitrypsin Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Alpha-1 Antitrypsin Drugs Sales by Regions (2016-2021) & (K Units)
Table 7. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Regions (2016-2021)
Table 8. Global Alpha-1 Antitrypsin Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Alpha-1 Antitrypsin Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 16. Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2016-2021)
Table 18. Global Alpha-1 Antitrypsin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Alpha-1 Antitrypsin Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2020)
Table 20. Key Manufacturers Alpha-1 Antitrypsin Drugs Price (2016-2021) (USD/Unit)
Table 21. Alpha-1 Antitrypsin Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Alpha-1 Antitrypsin Drugs Product Type
Table 23. Date of International Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021) (K Units)
Table 26. Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2016-2021)
Table 27. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2016-2021)
Table 29. Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Alpha-1 Antitrypsin Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021) (K Units)
Table 36. Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2016-2021)
Table 37. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Alpha-1 Antitrypsin Drugs Revenue Share by Application (2016-2021)
Table 39. Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. United States Alpha-1 Antitrypsin Drugs Sales (K Units) of Key Companies (2016-2021)
Table 46. United States Alpha-1 Antitrypsin Drugs Sales Share by Company (2016-2021)
Table 47. United States Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Company (2016-2021)
Table 48. United States Alpha-1 Antitrypsin Drugs Revenue Share by Company (2016-2021)
Table 49. United States Alpha-1 Antitrypsin Drugs Sales (K Units) by Type (2016-2021)
Table 50. United States Alpha-1 Antitrypsin Drugs Sales Share by Type (2016-2021)
Table 51. United States Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. United States Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2016-2021)
Table 53. United States Alpha-1 Antitrypsin Drugs Sales (K Units) by Type (2022-2027)
Table 54. United States Alpha-1 Antitrypsin Drugs Sales Share by Type (2022-2027)
Table 55. United States Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. United States Alpha-1 Antitrypsin Drugs Revenue Share by Type (2022-2027)
Table 57. United States Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2022-2027)
Table 58. United States Alpha-1 Antitrypsin Drugs Sales (K Units) by Application (2016-2021)
Table 59. United States Alpha-1 Antitrypsin Drugs Sales Share by Application (2016-2021)
Table 60. United States Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2016-2021)
Table 62. United States Alpha-1 Antitrypsin Drugs Sales (K Units) by Application (2022-2027)
Table 63. United States Alpha-1 Antitrypsin Drugs Sales Share by Application (2022-2027)
Table 64. United States Alpha-1 Antitrypsin Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States Alpha-1 Antitrypsin Drugs Revenue Share by Application (2022-2027)
Table 66. United States Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2022-2027)
Table 67. North America Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021) & (K Units)
Table 68. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2016-2021)
Table 69. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2016-2021)
Table 75. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021) & (K Units)
Table 76. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2016-2021)
Table 77. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2016-2021)
Table 79. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2016-2021)
Table 87. Baxter Corporation Information
Table 88. Baxter Description and Business Overview
Table 89. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Baxter Alpha-1 Antitrypsin Drugs Product
Table 91. Baxter Recent Development
Table 92. CSL Behring Corporation Information
Table 93. CSL Behring Description and Business Overview
Table 94. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. CSL Behring Product
Table 96. CSL Behring Recent Development
Table 97. Grifols Corporation Information
Table 98. Grifols Description and Business Overview
Table 99. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Grifols Product
Table 101. Grifols Recent Development
Table 102. Kamada Corporation Information
Table 103. Kamada Description and Business Overview
Table 104. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Kamada Product
Table 106. Kamada Recent Development
Table 107. Abeona Therapeutics Corporation Information
Table 108. Abeona Therapeutics Description and Business Overview
Table 109. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Abeona Therapeutics Product
Table 111. Abeona Therapeutics Recent Development
Table 112. Alnylam Pharmaceuticals Corporation Information
Table 113. Alnylam Pharmaceuticals Description and Business Overview
Table 114. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Alnylam Pharmaceuticals Product
Table 116. Alnylam Pharmaceuticals Recent Development
Table 117. Applied Genetic Technologies Corp Corporation Information
Table 118. Applied Genetic Technologies Corp Description and Business Overview
Table 119. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Applied Genetic Technologies Corp Product
Table 121. Applied Genetic Technologies Corp Recent Development
Table 122. Arrowhead Research Corporation Corporation Information
Table 123. Arrowhead Research Corporation Description and Business Overview
Table 124. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Arrowhead Research Corporation Product
Table 126. Arrowhead Research Corporation Recent Development
Table 127. Baxalta Corporation Information
Table 128. Baxalta Description and Business Overview
Table 129. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Baxalta Product
Table 131. Baxalta Recent Development
Table 132. Alpha-1 Antitrypsin Drugs Market Trends
Table 133. Alpha-1 Antitrypsin Drugs Market Drivers
Table 134. Alpha-1 Antitrypsin Drugs Market Challenges
Table 135. Alpha-1 Antitrypsin Drugs Market Restraints
Table 136. Alpha-1 Antitrypsin Drugs Customers List
Table 137. Alpha-1 Antitrypsin Drugs Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha-1 Antitrypsin Drugs Product Picture
Figure 2. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Parenteral Product Picture
Figure 4. Inhalation Product Picture
Figure 5. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020 & 2027
Figure 6. Drugstore
Figure 7. Hospital
Figure 8. Others
Figure 9. Alpha-1 Antitrypsin Drugs Report Years Considered
Figure 10. Global Alpha-1 Antitrypsin Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Alpha-1 Antitrypsin Drugs Market Size 2016-2027 (US$ Million)
Figure 12. Global Alpha-1 Antitrypsin Drugs Sales 2016-2027 (K Units)
Figure 13. Global Alpha-1 Antitrypsin Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2016-2021)
Figure 15. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2020
Figure 16. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2016-2021)
Figure 17. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region in 2020
Figure 18. Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Drugs Revenue in 2020
Figure 20. Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2021)
Figure 22. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020
Figure 23. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type in 2020
Figure 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2021)
Figure 26. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020
Figure 27. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2016-2021)
Figure 28. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application in 2020
Figure 29. United States Alpha-1 Antitrypsin Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 30. United States Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Alpha-1 Antitrypsin Drugs Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Alpha-1 Antitrypsin Drugs Players Market Share by Revenue in Alpha-1 Antitrypsin Drugs in 2020
Figure 33. United States Alpha-1 Antitrypsin Drugs Revenue Share by Type (2016-2021)
Figure 34. United States Alpha-1 Antitrypsin Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Alpha-1 Antitrypsin Drugs Revenue Share by Application (2016-2021)
Figure 36. United States Alpha-1 Antitrypsin Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Alpha-1 Antitrypsin Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2020
Figure 40. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2020
Figure 41. U.S. Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 42. U.S. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Alpha-1 Antitrypsin Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2020
Figure 48. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2020
Figure 49. Germany Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 60. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2020
Figure 62. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Region in 2020
Figure 63. China Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 64. China Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 66. Japan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 68. South Korea Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 70. India Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 72. Australia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 74. Taiwan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 76. Indonesia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 78. Thailand Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 80. Malaysia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Alpha-1 Antitrypsin Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 82. Philippines Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Alpha-1 Antitrypsin Drugs Sales Growth Rate (201

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs